A test for a wide range of genetic risk factors could improve doctors' ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.
Apr 8, 2015
0
19
(HealthDay)—The cell-cycle progression (CCP) gene panel is useful to improve the risk stratification for men with even low-risk, clinically localized prostate cancer, according to research published online March 4 in the ...
Mar 28, 2013
0
0
Reaching out to support a person when they're under stress is always a good idea. But a new study suggests that support could be especially important for someone whose genetic makeup makes them more likely to develop depression.
Jan 13, 2023
0
23
Each year, tens of thousands of babies are born in the United States as the result of IVF (in vitro fertilization) – where several eggs are fertilized outside the mother's body and then an embryo is selected for transfer ...
Oct 12, 2021
0
15
(HealthDay)—For women affected by familial breast cancer, a polygenic risk score based on 22 genomic variants can identify women at high-risk of breast cancer, according to a study published in the Dec. 10 issue of the ...
Dec 18, 2012
0
0
The heart and mind are strongly connected, with depression, anxiety and chronic stress all increasing the risk for heart and brain health complications, according to two preliminary studies to be presented at the American ...
Nov 6, 2023
0
2
Findings from the FinnGen study encompassing 120,000 women indicate that inherited breast cancer risk should be assessed in an increasingly comprehensive manner. Currently, only individual gene mutations are taken into consideration ...
Dec 14, 2020
0
9
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings ...
May 23, 2013
0
0
Among the tens of thousands of Americans with amyotrophic lateral sclerosis, or ALS, most do not have a single genetic mutation shown to cause the fatal disease.
Jun 21, 2023
0
7
Current United States Preventive Service Task Force (USPSTF) guidelines call for screening all Americans between the ages of 40 and 75 years to determine eligibility for statins, a class of cholesterol-lowering medications. ...
Jun 4, 2018
0
6
